Staloral

**Staloral** is a prescription sublingual allergen immunotherapy product family developed and commercialized by Stallergenes Greer. It consists of standardized, allergen-specific liquid extracts selected according to an individual patient's clinically relevant sensitizations; marketed presentations may include extracts of house dust mites, pollens, animal dander, and other aeroallergens. Administered under the tongue as a liquid solution, repeated exposure is intended to induce allergen-specific immune tolerance and reduce symptoms and rescue-medication use in respiratory allergy, including allergic rhinitis, conjunctivitis, rhinoconjunctivitis, and selected mild-to-moderate allergic asthma settings. Because the precise active allergen extract or extract mixture varies by Staloral presentation and prescription, Staloral is a branded allergen-immunotherapy range rather than one invariant molecular entity. ([stallergenesgreer.com](https://www.stallergenesgreer.com/press-releases/staloralrbirch-phase-iii-study-successfully-meets-primary-endpoint-demonstrating))

Brand names

Staloral

Other names

Staloral dust mites solution